- Home
- PRCT
as 12-20-2024 4:00pm EST
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | SAN JOSE |
| Market Cap: | 5.3B | IPO Year: | 2021 |
| Target Price: | $97.86 | AVG Volume (30 days): | 592.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.95 | EPS Growth: | N/A |
| 52 Week Low/High: | $39.48 - $103.81 | Next Earning Date: | 10-28-2024 |
| Revenue: | $199,843,000 | Revenue Growth: | 71.71% |
| Revenue Growth (this year): | 67.07% | Revenue Growth (next year): | 40.64% |
Stock Insider Trading Activity of PROCEPT BioRobotics Corporation (PRCT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Nouri Alaleh | PRCT | EVP, CLO, CORP. SEC. | Dec 4 '24 | Sell | $97.00 | 28,092 | $2,728,573.90 | 52,472 | |
| Zadno Reza | PRCT | President, CEO | Dec 4 '24 | Sell | $97.57 | 26,423 | $2,568,844.46 | 152,762 | |
| Zadno Reza | PRCT | President, CEO | Nov 27 '24 | Sell | $98.61 | 26,420 | $2,584,637.91 | 152,762 | |
| Zadno Reza | PRCT | President, CEO | Nov 20 '24 | Sell | $92.94 | 26,420 | $2,445,723.66 | 152,762 | |
| Zadno Reza | PRCT | President, CEO | Nov 13 '24 | Sell | $94.23 | 26,420 | $2,485,572.71 | 152,762 | |
| Desai Antal Rohit | PRCT | Director | Nov 5 '24 | Sell | $96.58 | 100,000 | $9,633,437.76 | 245,041 | |
| Zadno Reza | PRCT | President, CEO | Oct 30 '24 | Sell | $91.00 | 288,461 | $26,249,951.00 | 152,762 | |
| Waters Kevin | PRCT | EVP, CFO | Oct 15 '24 | Sell | $72.96 | 25,000 | $1,811,653.29 | 105,137 |
Latest PROCEPT BioRobotics Corporation News
PRCT Breaking Stock News: Dive into PRCT Ticker-Specific Updates for Smart Investing
MT Newswires
15 days ago
Procept Biorobotics Insider Sold Shares Worth $2,728,574, According to a Recent SEC Filing
MT Newswires
19 days ago
Procept Biorobotics Insider Sold Shares Worth $2,584,638, According to a Recent SEC Filing
MT Newswires
20 days ago
Morgan Stanley Initiates PROCEPT BioRobotics at Overweight
Insider Monkey
23 days ago
PROCEPT BioRobotics Corporation (PRCT) Gains 40% Following Strong Q3 Earnings and Upgraded Guidance
GlobeNewswire
25 days ago
PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024
MT Newswires
a month ago
Procept Biorobotics Insider Sold Shares Worth $2,485,573, According to a Recent SEC Filing
MT Newswires
a month ago
Procept BioRobotics Shares Decline After Jefferies Initiates Coverage at Hold
Zacks
a month ago
Are You Looking for a Top Momentum Pick? Why PROCEPT BioRobotics Corporation (PRCT) is a Great Choice
Compare PRCT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRCT PROCEPT BioRobotics Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.